Drug Interactions between fingolimod and teriflunomide
This report displays the potential drug interactions for the following 2 drugs:
- fingolimod
- teriflunomide
Interactions between your drugs
fingolimod teriflunomide
Applies to: fingolimod and teriflunomide
Talk to your doctor before using fingolimod together with teriflunomide. Combining these medications can increase the risk of serious infections. Rarely, these medications may also cause liver damage. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Because these drugs can stay in your blood for prolonged periods after the last dose (up to 2 months for fingolimod and 2 years for teriflunomide), interactions can occur even if you have stopped taking one medication and are starting the other. Contact your doctor immediately if you develop fever or other signs of infection during treatment with these medications, whether together or alone. You should also seek immediate medical attention if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, as these may be signs and symptoms of liver damage. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Immunomodulators for multiple sclerosis
Therapeutic duplication
The recommended maximum number of medicines in the 'immunomodulators for multiple sclerosis' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'immunomodulators for multiple sclerosis' category:
- fingolimod
- teriflunomide
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.